BioRestorative Therapies, Inc. (BRTX)
2.31
-0.02
(-0.86%)
USD |
NASDAQ |
Oct 01, 16:00
2.31
0.00 (0.00%)
After-Hours: 19:09
BioRestorative Therapies Cash from Operations (Annual) : -10.79M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -10.79M |
| December 31, 2024 | -8.230M |
| December 31, 2023 | -6.430M |
| December 31, 2022 | -5.913M |
| December 31, 2021 | -3.330M |
| December 31, 2020 | -1.964M |
| December 31, 2019 | -6.919M |
| December 31, 2018 | -5.105M |
| December 31, 2017 | -3.854M |
| Date | Value |
|---|---|
| December 31, 2016 | -5.003M |
| December 31, 2015 | -3.122M |
| December 31, 2014 | -3.228M |
| December 31, 2013 | -2.672M |
| December 31, 2012 | -3.184M |
| December 31, 2011 | -2.811M |
| December 31, 2010 | -0.7292M |
| December 31, 2009 | -0.2031M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Myriad Genetics, Inc. | 1.80M |
| CareDx, Inc. | 42.03M |
| Natera, Inc. | 215.30M |
| Exagen, Inc. | -13.62M |
| Sera Prognostics, Inc. | -25.62M |